Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean
breast cancer patients
Correspondence Dr Ntokozo Ndlovu, Department of Oncology, Faculty of
Medicine and Health Sciences, University of Zimbabwe, Harare Zimbabwe.
Email: ntokozosqo@gmail.com
Vincent Aketch Nyangwara1,2, Tinashe
Mazhindu1,4, Zedias Chikwambi1,2,
Collen Masimirembwa1, Margaret
Borok3 , Ntokozo Ndlovu4
1African Institute of Biomedical Science and
Technology, Harare, Zimbabwe
2Department of Biotechnology, Chinhoyi University of
Technology, Zimbabwe
3Unit of Internal Medicine, Faculty of Medicine and
Health Sciences, University of
Zimbabwe
4Department of Oncology, Faculty of Medicine and
Health Sciences, University of Zimbabwe
PI Statement: The authors confirm that the PIs for this paper were Prof.
Margaret Borok and Dr. Ntokozo Ndlovu and that they had direct clinical
responsibility for patients.
Key words: Anthracyclines; genetics; Zimbabwe, Africa, polymorphisms;
cardiology; risk monitoring; cardiovascular health.